MedTrace Logo

Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease

NCT01155492 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2013-05-30

No results posted yet for this study

Summary

The gut may be a portal of entry for agents that cause or contribute to the causes of Parkinson's disease (PD). The investigators are studying changes in the normal population of gut flora and in intestinal permeability and their associations with early PD.

Conditions

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Kathleen M Shannon, M.D. · Rush University Medical Center

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2012-12-31
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01155492 on ClinicalTrials.gov